Richard Chin Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard Chin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard Chin. Richard Chin is Director in OXIGENE INC ($OXGN) and President and CEO in OXIGENE INC ($OXGN) and Director in Galena Biopharma, Inc. ($GALE) and CEO in Kindred Biosciences, Inc. ($KIN) and Chief Executive Officer in Kindred Biosciences, Inc. ($KIN) and President & CEO in Kindred Biosciences, Inc. ($KIN) and President and CEO in Kindred Biosciences, Inc. ($KIN).
Latest Insider Trading Transactions of Richard Chin
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, KIN, MATN, SLS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 03 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | M | 0.00 | 12,500 | 0 | 25,000 | |
Feb 03 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 5.00 | 6,582 | 32,910 | 1,974,271 | 2 M to 2 M (-0.33 %) |
Feb 03 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Buy | M | 0.00 | 12,500 | 0 | 1,980,853 | 2 M to 2 M (+0.64 %) |
Jan 26 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | M | 0.00 | 37,500 | 0 | 37,500 | |
Jan 26 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 4.93 | 13,163 | 64,894 | 1,968,353 | 2 M to 2 M (-0.66 %) |
Jan 26 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 4.93 | 19,744 | 97,338 | 1,981,516 | 2 M to 2 M (-0.99 %) |
Jan 26 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Buy | M | 0.00 | 37,500 | 0 | 2,001,260 | 2 M to 2 M (+1.91 %) |
Jan 20 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | A | 4.44 | 394,000 | 1,749,360 | 394,000 | |
Jan 20 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | M | 0.00 | 37,500 | 0 | 112,500 | |
Jan 20 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 4.95 | 21,128 | 104,584 | 1,963,760 | 2 M to 2 M (-1.06 %) |
Jan 20 2021 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Buy | M | 0.00 | 37,500 | 0 | 1,984,888 | 1.9 M to 2 M (+1.93 %) |
Feb 13 2020 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
Feb 13 2020 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 9.22 | 4,317 | 39,803 | 1,947,388 | 2 M to 1.9 M (-0.22 %) |
Feb 13 2020 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Buy | M | 0.00 | 12,500 | 0 | 1,951,705 | 1.9 M to 2 M (+0.64 %) |
Jan 24 2020 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | M | 0.00 | 37,500 | 0 | 75,000 | |
Jan 24 2020 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 9.66 | 8,645 | 83,511 | 1,939,205 | 1.9 M to 1.9 M (-0.44 %) |
Jan 24 2020 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 9.88 | 11,607 | 114,677 | 1,947,850 | 2 M to 1.9 M (-0.59 %) |
Jan 24 2020 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Buy | M | 0.00 | 37,500 | 0 | 1,959,457 | 1.9 M to 2 M (+1.95 %) |
Jan 22 2020 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Jan 22 2020 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | A | 9.84 | 300,000 | 2,952,000 | 300,000 | |
Jan 22 2020 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Jan 22 2020 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | A | 9.84 | 300,000 | 2,952,000 | 300,000 | |
Feb 05 2019 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Feb 05 2019 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | A | 9.91 | 400,000 | 3,964,000 | 400,000 | |
Jan 24 2019 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Option Exercise | M | 0.00 | 37,500 | 0 | 112,500 | |
Jan 24 2019 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 9.95 | 8,646 | 85,984 | 1,921,957 | 1.9 M to 1.9 M (-0.45 %) |
Jan 24 2019 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Payment of Exercise | F | 10.12 | 12,968 | 131,236 | 1,930,603 | 1.9 M to 1.9 M (-0.67 %) |
Jan 24 2019 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Buy | M | 0.00 | 37,500 | 0 | 1,943,571 | 1.9 M to 1.9 M (+1.97 %) |
Jan 04 2019 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Sell | S | 10.57 | 40,000 | 422,716 | 1,906,071 | 1.9 M to 1.9 M (-2.06 %) |
Dec 04 2018 | KIN | Kindred Bioscience ... | Chin Richard | Chief Executive Off ... | Sell | S | 13.28 | 40,000 | 531,200 | 1,946,071 | 2 M to 1.9 M (-2.01 %) |
Nov 02 2018 | KIN | Kindred Bioscience ... | Chin Richard | CEO | Sell | S | 14.68 | 40,000 | 587,200 | 1,986,071 | 2 M to 2 M (-1.97 %) |
Oct 03 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Sell | S | 13.28 | 40,000 | 531,200 | 2,026,071 | 2.1 M to 2 M (-1.94 %) |
Sep 06 2018 | KIN | Kindred Bioscience ... | Chin Richard | PRESIDENT AND CEO | Sell | S | 14.69 | 7,600 | 111,644 | 2,066,071 | 2.1 M to 2.1 M (-0.37 %) |
Sep 06 2018 | KIN | Kindred Bioscience ... | Chin Richard | PRESIDENT AND CEO | Sell | S | 14.81 | 32,400 | 479,844 | 2,073,671 | 2.1 M to 2.1 M (-1.54 %) |
Aug 03 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Sell | S | 13.51 | 40,000 | 540,400 | 2,106,071 | 2.1 M to 2.1 M (-1.86 %) |
Jun 01 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Sell | S | 10.13 | 40,000 | 405,200 | 2,186,071 | 2.2 M to 2.2 M (-1.80 %) |
Jun 01 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Sell | S | 10.00 | 12,610 | 126,100 | 2,226,071 | 2.2 M to 2.2 M (-0.56 %) |
May 29 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Sell | S | 10.00 | 3,000 | 30,000 | 2,238,681 | 2.2 M to 2.2 M (-0.13 %) |
May 29 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Sell | S | 10.00 | 60 | 600 | 2,241,681 | 2.2 M to 2.2 M (0.00 %) |
May 18 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Sell | S | 10.00 | 2,400 | 24,000 | 2,241,741 | 2.2 M to 2.2 M (-0.11 %) |
May 09 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Sell | S | 10.00 | 200 | 2,000 | 2,244,141 | 2.2 M to 2.2 M (-0.01 %) |
May 09 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Sell | S | 10.01 | 1,730 | 17,317 | 2,244,341 | 2.2 M to 2.2 M (-0.08 %) |
May 02 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Sell | S | 9.05 | 20,000 | 181,000 | 2,246,071 | 2.3 M to 2.2 M (-0.88 %) |
Apr 04 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Sell | S | 8.39 | 20,000 | 167,800 | 2,266,071 | 2.3 M to 2.3 M (-0.87 %) |
Jan 24 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Jan 24 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Option Exercise | A | 8.75 | 175,000 | 1,531,250 | 175,000 | |
Jan 24 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Payment of Exercise | F | 9.15 | 11,475 | 104,996 | 2,286,071 | 2.3 M to 2.3 M (-0.50 %) |
Jan 24 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Jan 24 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Option Exercise | A | 8.75 | 175,000 | 1,531,250 | 175,000 | |
Jan 24 2018 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Payment of Exercise | F | 9.15 | 11,475 | 104,996 | 2,286,071 | 2.3 M to 2.3 M (-0.50 %) |
Oct 10 2017 | GALE | Galena Biopharma, ... | Chin Richard | Director | Grant | A | 0.38 | 12,708 | 4,829 | 31,339 | 18.6 K to 31.3 K (+68.21 %) |
Jul 06 2017 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Sell | S | 8.26 | 13,000 | 107,380 | 2,297,546 | 2.3 M to 2.3 M (-0.56 %) |
Jul 06 2017 | GALE | Galena Biopharma, ... | Chin Richard | Director | Option Exercise | A | 0.55 | 5,000 | 2,750 | 5,000 | |
Jul 06 2017 | GALE | Galena Biopharma, ... | Chin Richard | Director | Grant | A | 0.59 | 8,104 | 4,781 | 18,631 | 10.5 K to 18.6 K (+76.98 %) |
Jun 26 2017 | KIN | Kindred Bioscience ... | Chin Richard | President and CEO | Sell | S | 7.75 | 13,000 | 100,750 | 2,310,546 | 2.3 M to 2.3 M (-0.56 %) |
Apr 12 2017 | GALE | Galena Biopharma, ... | Chin Richard | Director | Grant | A | 0.59 | 8,107 | 4,783 | 10,527 | 2.4 K to 10.5 K (+335.00 %) |
Jan 25 2017 | KIN | Kindred Bioscience ... | Chin Richard | President & CEO | Option Exercise | A | 6.40 | 175,000 | 1,120,000 | 175,000 | |
Jan 25 2017 | KIN | Kindred Bioscience ... | Chin Richard | President & CEO | Grant | A | 0.00 | 100,000 | 0 | 2,323,546 | 2.2 M to 2.3 M (+4.50 %) |
Jan 25 2017 | KIN | Kindred Bioscience ... | Chin Richard | President & CEO | Gift | G | 0.00 | 400,000 | 0 | 2,223,546 | 2.6 M to 2.2 M (-15.25 %) |
Jan 24 2017 | GALE | Galena Biopharma, ... | Chin Richard | Director | Grant | A | 1.98 | 2,420 | 4,792 | 2,420 | 0 to 2.4 K |
Jul 18 2016 | GALE | Galena Biopharma, ... | Chin Richard | Director | Option Exercise | A | 0.41 | 100,000 | 41,000 | 100,000 | |
Jan 12 2016 | KIN | Kindred Bioscience ... | Chin Richard | President & CEO | Option Exercise | A | 3.45 | 197,771 | 682,310 | 197,771 | |
Jun 23 2015 | GALE | Galena Biopharma, ... | Chin Richard | Director | Option Exercise | A | 1.77 | 100,000 | 177,000 | 100,000 | |
Aug 03 2006 | OXGN | OXIGENE INC | Chin Richard | President and CEO | Buy | P | 3.30 | 16,067 | 53,021 | 60,000 | 43.9 K to 60 K (+36.57 %) |
Aug 03 2006 | OXGN | OXIGENE INC | Chin Richard | President and CEO | Buy | P | 3.28 | 1,100 | 3,608 | 43,933 | 42.8 K to 43.9 K (+2.57 %) |
Aug 03 2006 | OXGN | OXIGENE INC | Chin Richard | President and CEO | Buy | P | 3.29 | 2,833 | 9,321 | 42,833 | 40 K to 42.8 K (+7.08 %) |
Jul 07 2006 | OXGN | OXIGENE INC | Chin Richard | President and CEO | Option Exercise | A | 4.08 | 250,000 | 1,020,000 | 250,000 | |
Aug 30 2005 | OXGN | OXIGENE INC | Chin Richard | Director | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Page: 1